These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23809736)

  • 1. [Cancer and deep venous thrombosis: the purpose of the CATCH clinical trial].
    Araújo A
    Acta Med Port; 2013; 26(2):83-5. PubMed ID: 23809736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis and cancer.
    Kakkar AK
    Hematol J; 2004; 5 Suppl 3():S20-3. PubMed ID: 15190272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of catheter-related thrombosis in cancer patients.
    Prandoni P
    Lancet; 2009 Feb; 373(9663):523-4. PubMed ID: 19217973
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylaxis and treatment of venous thromboembolism in patients with cancer.
    Ageno W; Squizzato A
    Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heparin and cancer].
    Lykke J
    Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
    Caine GJ; Lip GY
    Arch Intern Med; 2003 May; 163(10):1243-4; author reply 1244. PubMed ID: 12767973
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
    Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Venous thromboembolism in oncologic patients: guidelines for prevention and therapy and areas of uncertainty].
    Di Minno G; Tufano A
    Tumori; 2006; 92(6):suppl 1-15. PubMed ID: 17260505
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
    Cunningham RS
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controversies in oncology. Venous thromboembolism and cancer: what is done and what should be done. Milan, May 18, 2002].
    Tumori; 2002; 88(4):A8-17. PubMed ID: 12402833
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer and venous thromboembolism.
    Prandoni P; Falanga A; Piccioli A
    Lancet Oncol; 2005 Jun; 6(6):401-10. PubMed ID: 15925818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we optimise treatment of thrombosis?
    Levine MN
    Cancer Treat Rev; 2003 Jun; 29 Suppl 2():19-22. PubMed ID: 12887946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of venous thromboembolism in cancer patients.
    Lee AY; Levine MN
    Oncology (Williston Park); 2000 Mar; 14(3):409-17, 421; discussion 422, 425-6. PubMed ID: 10742967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Venous thromboembolism and cancer].
    Pavic M; Debourdeau P; Aletti M; Farge-Bancel D; Rousset H
    Rev Med Interne; 2006 Apr; 27(4):313-22. PubMed ID: 16414153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of deep vein thrombosis in cancer patients.
    Jahanzeb M
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer and thrombosis: an increasingly important association.
    Korte W
    Support Care Cancer; 2008 Mar; 16(3):223-8. PubMed ID: 18197438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
    Levine M
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of current and emerging antithrombotics in thrombosis and cancer.
    Mousa SA
    Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism and prophylaxis in cancer patients.
    Paskauskas S; Pundzius J; Barauskas G
    Medicina (Kaunas); 2008; 44(3):175-81. PubMed ID: 18413983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.